205 related articles for article (PubMed ID: 12221676)
1. Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
Smythe MA; Warkentin TE; Stephens JL; Zakalik D; Mattson JC
Am J Hematol; 2002 Sep; 71(1):50-2. PubMed ID: 12221676
[TBL] [Abstract][Full Text] [Related]
2. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Warkentin TE
Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
[TBL] [Abstract][Full Text] [Related]
3. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Warkentin TE
Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
[No Abstract] [Full Text] [Related]
4. Heparin-induced thrombocytopenia: a ten-year retrospective.
Warkentin TE
Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia.
Warkentin TE; Elavathil LJ; Hayward CP; Johnston MA; Russett JI; Kelton JG
Ann Intern Med; 1997 Nov; 127(9):804-12. PubMed ID: 9382401
[TBL] [Abstract][Full Text] [Related]
6. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.
Srinivasan AF; Rice L; Bartholomew JR; Rangaswamy C; La Perna L; Thompson JE; Murphy S; Baker KR
Arch Intern Med; 2004 Jan; 164(1):66-70. PubMed ID: 14718324
[TBL] [Abstract][Full Text] [Related]
7. Comment: treatment of heparin-induced thrombocytopenia.
Smythe MA; Warkentin TE
Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
[No Abstract] [Full Text] [Related]
8. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
Warkentin TE
Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
[TBL] [Abstract][Full Text] [Related]
9. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Bartholomew JR; Hursting MJ
J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
[TBL] [Abstract][Full Text] [Related]
10. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Bartholomew JR
Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
[TBL] [Abstract][Full Text] [Related]
11. Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.
Warkentin TE; Cook RJ; Sarode R; Sloane DA; Crowther MA
Blood; 2015 Jul; 126(4):486-93. PubMed ID: 25979950
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for heparin-induced thrombocytopenia.
Greinacher A
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
[TBL] [Abstract][Full Text] [Related]
13. Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
Januzzi JL; Jang IK
J Thromb Thrombolysis; 1999 Jun; 7(3):259-64. PubMed ID: 10375387
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous lepirudin for heparin-induced thrombocytopenia and when other anticoagulants fail: illustrative cases.
Deitcher SR; Ngengwe R; Kaplan R; Liebman H; Kaplan K; Blinder M
Clin Adv Hematol Oncol; 2004 Jun; 2(6):382-4; discussion 384-6. PubMed ID: 16163209
[No Abstract] [Full Text] [Related]
18. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
19. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Hursting MJ; Lewis BE; Macfarlane DE
Clin Appl Thromb Hemost; 2005 Jul; 11(3):279-87. PubMed ID: 16015413
[TBL] [Abstract][Full Text] [Related]
20. Heparin induced thrombocytopenia: diagnosis and management update.
Ahmed I; Majeed A; Powell R
Postgrad Med J; 2007 Sep; 83(983):575-82. PubMed ID: 17823223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
